WALTHAM, MA - April 23, 2026 - - KACTUS has published a technical framework for engineering 2+1 and trispecific T-cell engager therapeutics, addressing structural scaffold challenges for drug ...
At AACR 2026, prominent cancer researchers discussed the latest advances in mitigating tumor evasion, targeting cancer ...
How do cells know when to activate or slow down their activity? A team from the University of Geneva (UNIGE) provides new ...
An international team of researchers has identified an East African bat coronavirus capable of entering human cells. Whilst the virus - Cardioderma cor coronavirus (CcCoV) KY43, or CcCoV-KY43 – can ...
April 22, 2026 expert reaction to study looking at whether a bat alphacoronavirus can enter human cells . A study published in Nature looks at whether a bat alphacoronavirus can b ...
Variants in GLP‑1 and GIP receptor genes partly determine weight loss and nausea risk on GLP‑1 drugs, signaling a shift from ...
Variants in GLP‑1 and GIP receptor genes partly determine weight loss and nausea risk on GLP‑1 drugs, signaling a shift from ...
Explore 25 rare brain abilities only a tiny fraction of people have, from tetrachromacy to echolocation. Uncover the ...
Morning Overview on MSN
New neuron map reveals potential drug targets for chronic pain
Chronic pain affects roughly 51 million adults in the United States alone, and for most of them, the available drug options ...
Chimeric antigen receptor (CAR) T-cell therapy is an impactful treatment for blood cancers, such as leukemia and lymphoma. However, the immunotherapy has struggled against solid tumors, as tumor cells ...
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results